GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9%
Fri, 25 Oct

GSK PHARMA has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

GSK PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-18*
3
Jun-19*
3
Sep-19*
QoQ ChangeYoY Change
Net SalesRs m8,1637,8808,82111.9%8.1%
Other incomeRs m148305156-48.9%5.3%
TurnoverRs m8,3118,1868,9779.7%8.0%
ExpensesRs m6,5126,2256,87910.5%5.6%
Gross profitRs m1,5341,6555,954259.8%288.2%
DepreciationRs m11519122719.1%97.4%
InterestRs m299-1.1%318.2%
Profit before taxRs m1,5651,7605,874233.7%275.4%
TaxRs m55762684635.2%51.9%
Profit after taxRs m1,0081,1355,028343.1%398.9%
Gross profit margin%18.821.067.5
Effective tax rate%35.635.514.4
Net profit margin%12.113.956.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 8.1% on a year-on-year (YoY) basis. The expenses were up by 5.6% YoY during the same period.
  • The company's operating profit increased by 288.2% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 67.5% in 2QFY20 as against 18.8% in 2QFY19.
  • Depreciation charges increased by 97.4% and finance costs increased by 318.2% YoY, respectively.
  • Other income increased by 5.3% YoY during the quarter.
  • Net profit for the quarter increased by 398.9% YoY. Net profit margins during the quarter increased from 12.1% in 2QFY19 to 56.0% in 2QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 11.9% on a quarter-on-quarter (QoQ) basis. The expenses were up by 10.5% QoQ during the same period.
  • The company's operating profit increased by 259.8% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 67.5% in 2QFY20 as against 21.0% in 1QFY19.
  • Net profit for the quarter increased by 343.1% QoQ, while net profit margins increased from 13.9% in 1QFY19 to 56.0% in 2QFY20.

To see how GSK PHARMA has performed over the last eight quarters,please visit here.

RELEASED! Richa Agarwal's No. 1 Stock Pick for 2021

GSK PHARMA Share Price Performance

Over the last one year,GSK PHARMA share price has moved up from Rs 1,283.6 to Rs 1,507.9, registering a Gain of Rs 224.3 or around 17.5%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,848.3 (down 0.3%). Over the last one year it has moved down from 13,909.4 to 12,848.3, a gain of 1,061 points (down 7.6%).

Overall, the S&P BSE SENSEX is up 14.6% over the year.

Current Valuations

At the current price of Rs 1,507.9, the price to earnings (P/E) ratio of GSK PHARMA stands at 30.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 11.9 times.

Equitymaster requests your view! Post a comment on "GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9%". Click here!

  

Related Views on News

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers(Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

My Top Stock to Buy in this Market Selloff(Profit Hunter)

Sep 22, 2020

The recent correction offers a great opportunity to buy this high conviction smallcap stock.

What Do the Charts Say About Buying Smallcaps Now?(Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

Can the Nifty Fall to 10,200?(Fast Profits Daily)

Sep 24, 2020

The Nifty has reached an important support level today. If it breaks then we could see further downside.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Sep 25, 2020 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - ADCOCK INGRAM COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS